Sandra Kelley
Family · Columbus, GANPI 1699731679
Payments from drug & device makers
Across 120 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$580
- Pfizer$381
- AbbVie$278
- Exeltis, USA Inc.$215
- Sumitomo Pharma America, Inc.$119
- Bayer$100
- plus $807 from 20 others
What the payments were for
- Food & beverage$2,06183%
- Education$41917%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 13 | $580 |
| Pfizer | 27 | $381 |
| AbbVie | 15 | $278 |
| Exeltis, USA Inc. | 10 | $215 |
| Sumitomo Pharma America, Inc. | 7 | $119 |
| Bayer | 6 | $100 |
| Medtronic | 3 | $87 |
| Scynexis, Inc. | 4 | $75 |
| Mylan Pharmaceuticals Inc. | 5 | $75 |
| Evofem Biosciences, Inc. | 4 | $73 |
| Myovant Sciences Inc. | 5 | $67 |
| Biogen | 2 | $46 |
| Therapeuticsmd, Inc. | 3 | $44 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Coopersurgical, Inc. | 2 | $42 |
| Exact Sciences | 2 | $35 |
| Karyopharm Therapeutics Inc. | 1 | $34 |
| Bristol Myers Squibb | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Avion Pharmaceuticals | 1 | $21 |
| LSI Solutions Inc | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Axonics, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
How this compares
$2,480 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 83 | $2,852 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 14 | $1,598 |
| ValacyclovirValacyclovir Hcl | 21 | $1,235 |
| Tolterodine Tartrate ErTolterodine Tartrate | 15 | $910 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 15 | $519 |
| Medroxyprogesterone Acetate | 21 | $227 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $164 |
| Fluconazole | 15 | $64 |
Paid to pharmacies, not to this prescriber.
Other family in Columbus
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.